ELVANSE caps 70 mg bte 30 pce
7680630230034
CH-63023
N06BA12
01.10.2.
Reimbursement limitations:
ELVANSE
Enfants et adolescents:
Uniquement pour le traitement de deuxième ligne du trouble déficitaire de l'attention …
1 / 3
google
Details
- Product number
- 6302303
- CPT
- -
- Packaging group
- 30
- Unit
- Kapsel(n)
- Composition
- lisdexamfetamini dimesilas 70 mg corresp. dexamfetaminum 20.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 127, E 133, E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.3588 mg.
Articles (1)
Elvanse 70 mg, Hartkapseln
Kapseln
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
70.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
20.8 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FIMDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
0.3588 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 141.10
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2014
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 63023
- Drug name
- Elvanse, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- N06BA12
- Authorization status
- Z
- Dispensation category
- A+
- First authorization
- 27/03/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 01.10.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ELVANSE caps 70 mg bte 30 pce
- Description (DE)
- ELVANSE Kaps 70 mg Ds 30 Stk
- Market launch
- 27/03/2014
- Narcotic (BTM)
- A